DJIA 17,550.69 -47.51 -0.27%
NASDAQ 5,105.55 -9.84 -0.19%
S&P 500 2,093.32 -4.72 -0.22%
market minute promo

AstraZeneca plc (ADR) (NYSE: AZN)



company name or ticker
Company Photos
(Click to zoom)

AstraZeneca's MedImmune, Mirati Therapeutics Partner on Immuno-oncology Combination in Lung Cancer

Sell This Best-Of-Breed Pharma Major In The Short Term

Isis' News-Filled Week

The biotech announces a new partnership, clinical trial results, and earnings over the course of two days.

A Post-Earnings Review Of Amgen, With Discussion Of The Repatha Launch

Premarket Biotech Digest: Gilead HIV, Eliquis Trial Errors, Clinical Trial Phases

Isis Pharma 8-K Filing Shows Company Enters Agreement with Astrazeneca To Discover And Develop Antis

Isis Pharma 8-K Filing Shows Company Enters Agreement with Astrazeneca To Discover And Develop Antisense Drugs FOr Cardiovascular, Metabolic And Renal Disease

AstraZeneca, Isis Pharmaceuticals to Collaborate to Develop Antisense Drugs for Cardiovascular, Meta

AstraZeneca, Isis Pharmaceuticals to Collaborate to Develop Antisense Drugs for Cardiovascular, Metabolic and Renal Diseases

Healthcare: 9.6% More Net Gains From 5 Highest Yield, Lowest Priced July 29 Dogs

10 Top Healthcare Dividend Dogs: 11% To 47.9% Upsides And 12.1% To 48.3% Net Gains As Of July 29

Healthcare Dividend Dogs: 3% To 10% Yields From Top 10 As Of July 29

See More Articles...